Co-Authors
This is a "connection" page, showing publications co-authored by MICHAEL SCHEURER and CHRIS AMOS.
Connection Strength
0.742
-
Rare deleterious germline variants and risk of lung cancer. NPJ Precis Oncol. 2021 Feb 16; 5(1):12.
Score: 0.201
-
Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium. Eur J Cancer. 2013 Apr; 49(6):1335-45.
Score: 0.114
-
A variable age of onset segregation model for linkage analysis, with correction for ascertainment, applied to glioma. Cancer Epidemiol Biomarkers Prev. 2012 Dec; 21(12):2242-51.
Score: 0.112
-
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut. 2024 Feb 16.
Score: 0.062
-
Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2019 03; 28(3):555-562.
Score: 0.043
-
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. J Thorac Oncol. 2018 10; 13(10):1483-1495.
Score: 0.042
-
History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Cancer Med. 2016 06; 5(6):1352-8.
Score: 0.036
-
Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):282-90.
Score: 0.035
-
Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer. J Thorac Oncol. 2016 Jan; 11(1):52-61.
Score: 0.035
-
The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium. Am J Epidemiol. 2016 Jan 15; 183(2):85-91.
Score: 0.035
-
Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma. Hum Genet. 2012 Sep; 131(9):1507-17.
Score: 0.027